LONDON, Nov. 6, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the third quarter ended September 30, 2024.Third Quarter 2024 Financial Highlights Revenues of $622.2 million decreased 3.9% Organic revenues decreased 2.6%, as an increase in subscription revenues of 0.6% was offset by a decrease in re-occurring revenues of 1.1% and transactional and other revenues of 13.6% Net loss of $65.6 mil ...

Wall Street analysts expect Clarivate PLC (CLVT) to post quarterly earnings of $0.19 per share in its upcoming report, which indicates a year-over-year decline of 9.5%. Revenues are expected to be $640.01 million, down 1.1% from the year-ago quarter.The current level reflects a downward revision of 1.1% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.Ahead of a ...

Financial Results Announcement - Clarivate Plc will report its financial results for the third quarter of 2024 before the market opens on November 6, 2024 [1] - The press release and earnings supplement will be available on the Clarivate investor website [1] Conference Call Details - A conference call and webcast will be held at 9:00 AM Eastern Time on November 6, 2024, to review the results [2] - The live webcast will be accessible through the investor relations section of the Company's website [2] Access Information - Interested parties can access the live audio broadcast via phone, with U.S. participants calling 800-715-9871 and international participants calling +1 646-307-1963 [3] - A replay of the webcast will be available on the investor website two hours after the live call and will remain accessible for one year [3] Company Overview - Clarivate is a leading global provider of transformative intelligence, offering data, insights, analytics, workflow solutions, and expert services in various sectors including Academia & Government, Intellectual Property, and Life Sciences & Healthcare [4]

83 Citation Laureates named by the Institute for Scientific Information have received a Nobel Prize since 2002 LONDON, Oct. 15, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the success of its annual Citation Laureates™ program, following the accurate forecast of eight Nobel Prize 2024 recipients. Powered by trusted, high-quality data from the Web of Science Core Collection™ citation index, the Citation Laureates program combines ri ...

Top industry leaders to explore AI, data, strategic partnerships, and innovation opportunities in Latin America at premier Life Sciences event LONDON, Oct. 4, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) a leading global provider of transformative intelligence, today announced the full agenda for the 2nd annual Summit LATAM, which will be held in Milan on October 7, 2024, ahead of the CPHI Milan conference. In partnership with the Brazilian Association of the Pharmaceutical Ingredients Industry (Abiquifi ...

LONDON, Sept. 25, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the development of a comprehensive framework for evaluating the societal impact of research. The approach has been outlined in a new report published today by the Institute for Scientific Information (ISI)™ to address the growing demand for demonstrating the benefits of research and development (R&D) investments across various sectors of society. The report, A responsib ...

Sharing benchmarks and strategies to elevate IP practices LONDON, Sept. 24, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today released a new survey-based report that reveals insights and best practices for optimizing intellectual property (IP) operations. In the Excellence in IP Operations report, experts highlight challenges and opportunities facing IP operations departments through the lens of strategy alignment, resource allocation, technolog ...

Core Insights - Clarivate Plc has announced a strategic partnership with Relatable Healthcare to enhance product data management and competitive conversion efficiency for medtech sales, contracting, and pricing teams [1][3]. Group 1: Partnership Overview - The partnership aims to provide a Product Relationship Management (PRM) platform that serves as a single source of truth for product information and competitive data, facilitating cost-efficient revenue growth for medtech manufacturers and distributors [2][5]. - The collaboration combines Clarivate's market intelligence with Relatable's enterprise software, equipping medtech companies with insights and tools to improve contract compliance and win new business [5]. Group 2: Platform Features - The Relatable™ platform offers comprehensive competitive intelligence, product specifications, inventory availability, sales collateral, and custom proprietary data management, enabling clients to make informed strategic pricing decisions [3][4]. - The platform supports streamlined sales contracting processes and enhances contract compliance by providing tools and insights for managing the entire contracting cycle effectively [3][4]. Group 3: Industry Challenges - Medtech companies face challenges in communicating product value and analyzing market trends, particularly in a cost-constrained healthcare environment where providers rigorously evaluate purchasing decisions [4]. - To address these challenges, medtech companies require up-to-date competitive intelligence and advanced software to tailor insights for each contracting and sales opportunity [4].

Core Insights - Clarivate Plc has released the Citation Laureates™ 2024 list, which identifies 22 exceptional scientists and economists whose work is considered of Nobel stature, often predicting future Nobel Prize recipients [1][2][3] Group 1: Contributions and Impact - The 2024 Citation Laureates have made significant advancements in various fields, including clean energy, nanotechnology, 3D protein structures, and the economic impact of corruption [2][3] - The laureates are based in leading academic institutions and corporate organizations, with 11 from the United States, six from the United Kingdom, and others from Switzerland, Germany, Israel, and Japan [3] Group 2: Notable Laureates and Their Work - Key figures include Jonathan C. Cohen and Helen H. Hobbs for their research on lipid metabolism leading to new cardiovascular drugs [5] - John M. Jumper and Demis Hassabis from Google DeepMind are recognized for their contributions to AI and protein structure prediction, with AlphaFold being utilized by over 2 million researchers [4][5] - In economics, Janet Currie is acknowledged for her pioneering analysis of child development, while Partha Dasgupta integrates nature into economic frameworks [7] Group 3: Methodology and Historical Context - Since 2002, Clarivate's Institute for Scientific Information has identified potential Nobel Prize recipients based on citation data from the Web of Science, with only 0.01% of indexed articles cited over 2,000 times [4] - The upcoming Nobel Prize announcements are scheduled for October 7-14, 2024, and will be streamed live [8] Group 4: Company Overview - Clarivate is a global provider of transformative intelligence, offering data, insights, and analytics across various sectors, including academia, government, and life sciences [9]

Transforming library discovery with Academic AI that provides users a new and easy way to find trusted content LONDON, Sept. 18, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today launched Primo™ Research Assistant. Developed in collaboration with partners from the library community, the new generative AI-powered library discovery solution offers a seamless experience for students and researchers. It provides immediate answers to natural language ...